Phibro Animal Health (PAHC) Cost of Revenue (2012 - 2026)

Phibro Animal Health's Cost of Revenue history runs 15 years deep, the most recent figure standing at $257.9 million for Q1 2026.

• In Q1 2026, Cost of Revenue rose 6.01% year-over-year to $257.9 million; the TTM figure through Mar 2026 stood at $1.0 billion (up 24.38% YoY), while the FY2025 annual figure was $896.3 million, up 27.21% from the prior year.
• Cost of Revenue was $257.9 million for Q1 2026 at Phibro Animal Health, up from $241.3 million in the prior quarter.
• In the past five years, Cost of Revenue ranged from a high of $268.7 million in Q2 2025 to a low of $163.6 million in Q3 2023.
• Historically, Cost of Revenue has averaged $198.2 million across 5 years, with a median of $178.4 million in 2023.
• The sharpest annual moves came in 2023 and 2025: Cost of Revenue fell 0.15% in 2023, then jumped 44.45% in 2025.
• A 5-year view of Cost of Revenue shows it stood at $167.3 million in 2022, then climbed by 2.43% to $171.3 million in 2023, then advanced by 21.05% to $207.4 million in 2024, then rose by 16.33% to $241.3 million in 2025, then increased by 6.89% to $257.9 million in 2026.
• The last three Cost of Revenue figures came in at $257.9 million (Q1 2026), $241.3 million (Q4 2025), and $244.1 million (Q3 2025), per Business Quant data.